| Speeches
Session 1 – Setting the scene
Session 2: Key Note Thematic Presentations
Session 3: Parallel Break Out Sessions
Speeches
- Welcome Address(35KB)
Androulla Vassiliou, Commissioner for Health, European Commission
Presentations Session 1 – Setting the scene - Overview of the role of RA in decision making (300KB)
John D. Graham
Indiana University, School of Public and Environmental Affairs - Proposed aims and suggested scope and Contents for the RA dialogue(85KB)
Bernardo Delogu, Head of Unit Risk Assessment
Health and Consumers Directorate General, European Commission - Presentations of the Regulatory Risk Assessment process in the EU, US and Canada(525KB)
Joint presentation by:
Takis Daskaleros
Health and Consumers Directorate General, European Commission
Nancy Beck
US Office of Management of the Budget
John Giraldez
Regulatory Affairs Division, Treasury Board of Canada - Presentations of the Regulatory Risk Assessment process in:
- Japan(990KB)
Hidetaka Kobayashi, Associate Director
Food Safety and Consumer Policy Division, Food Safety and Consumer Affairs Bureau, Japan Ministry of Agriculture, Forestry and Fisheries - China(335KB)
Junshi Chen, Senior Research Professor
Institute of Nutrition and Food Safety, Chinese Centre for Diseases Control and Prevention - Australia(400KB)
David Heinrich, Manager
America, New Zealand, Europe and Africa Team, Plant Biosecurity, Australia - Russia(140KB)
Simon Avaliani, Head
Department of the Communal Hygiene, Centre for the Risk Assessment, Russian Academy of the Advanced Medical Studies
- An Overview of Risk Assessment Policy Issues: Experience and Current Problems
- Risk Assessment Policy: an interface between risk assessment and risk management(140KB)
Erik Millstone
SPRU - Science and Technology Policy Research Freeman Centre, University of Sussex - Risk Assessment and Risk Management: A Perspective From FDA(50KB)
Randall Lutter, Deputy Commissioner for Policy
US Food and Drug Administration - Risk Assessment & Risk Management(135KB)
James K. Hammit, Professor of Economics and Decision Sciences
Department of Health and Policy Management, Harvard University School of Public Health, Boston, Massachusetts, USA - An overview of scientific issues in risk assessment: Where are we and where should we be going?(60KB)
Jim Bridges, Chair of the European Commission Scientific Committee on Emerging and Newly Identified Health Risks (SCENIHR) - Ever increasing number of policies and risk assessments at global level – are they efficient?(1.3MB)
Gernot Klotz, Executive Director
Research and Innovation, European Chemical Industry Council (CEFIC)
Session 2: Key Note Thematic Presentations - Risk Assessment Terminology, Expression of Nature and Level of Risk and of Uncertainties(550KB)
Anthony Hardy, Chair of the European Food Safety Authority (EFSA) Plant Protection Panel - Considerations in light of the WHO/IPCS guidelines on expression of uncertainties(640KB)
Gerhard Heinemeyer, Chair of WHO/IPCS Working Group on Uncertainty in Exposure Assessment
Federal Institute for Risk Assessment, Germany - Overview of activities to identify and assess new and emerging issues and challenges related to chemical, physical, and biological agents(300KB)
George Gray, Assistant Administrator for the Office of Research and Development
US Environmental Protection Agency - State of the art in the European Union on monitoring and assessing emerging risks(360KB)
Vittorio Silano, Chair of the Scientific Committee of the European Food Safety Authority (EFSA) - Presentation of the Commission Scientific Committees draft opinion on the approach to the assessment of carcinogens and mutagens (190KB)
Helmut Greim, Chair of the Scientific Committee on Health and Environmental Risks (SCHER) - Presentation of EPA's Weight of evidence approach (350KB)
Vicki Dellarco
Health Effects Division, Office of Pesticide Programmes, US Environmental Protection Agency - Presentation of the key aspects of exposure assessment in RA: needs and challenges (430KB)
Antonia M. Calafat
Division of Laboratory Sciences, National Center for Environmental Health, US Centers of Disease Control and Prevention - Invited comments(800KB)
William Ross, Director
Health Canada, Bureau of Biostatistics
Session 3: Parallel Break Out Sessions 1) Terminology 2) Non-Threshold Carcinogens 3) Emerging Issues and Challenges 4) Exposure Assessment |
